Clinical Trials Directory

Trials / Completed

CompletedNCT03063918

Personalized Dietary Intervention in Managing Bowel Dysfunction and Improving Quality of Life in Stage I-III Rectosigmoid Cancer Survivors

Pilot Study of a Personalized Dietary Intervention to Manage Bowel Dysfunction in Rectal Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
City of Hope Medical Center · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well personalized dietary intervention works in managing bowel dysfunction and improving quality of life in stage I-III rectosigmoid cancer survivors. Personalized dietary intervention may help people understand bowel symptoms, identify helpful and troublesome foods for bowel symptoms, adjust diets and food preparation based on food triggers, and coach on healthy diet recommendations after cancer treatment.

Detailed description

PRIMARY OBJECTIVES: I. Administer and determine the feasibility of the personalized dietary intervention. II. Using qualitative methods, evaluate the acceptability of the intervention as reported by survivors. III. Explore decisional conflict associated with treatment decision-making in rectal cancer surgery. OUTLINE: At 6 months after standard of care treatment, patients receive 10 sessions of personalized dietary intervention over 30 minutes each over 4 months via the telephone. Patients also receive a workbook including reference materials and intervention content. After completion of study, patients are followed up for 6 months.

Conditions

Interventions

TypeNameDescription
OTHERInformational InterventionReceive a workbook
OTHERQuality-of-Life AssessmentAncillary studies
OTHERQuestionnaire AdministrationAncillary studies
OTHERSurvey AdministrationAncillary studies
BEHAVIORALTelephone-Based InterventionReceive personalized dietary intervention

Timeline

Start date
2017-04-28
Primary completion
2021-09-07
Completion
2021-09-07
First posted
2017-02-24
Last updated
2024-02-22

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03063918. Inclusion in this directory is not an endorsement.